← Browse by Condition
Medical Condition
urothelial carcinoma
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 3, Phase 1, Phase 2, Phase 2
NCT06774131 Phase 3
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Enrollment
70 pts
Location
United States, Bulga...
Sponsor
UroGen Pharma Ltd.
NCT06047379 Phase 1, Phase 2
Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
NCT05600127 Phase 2
Recruiting
Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer
Enrollment
64 pts
Location
Netherlands
Sponsor
Erasmus Medical Center
NCT05239624 Phase 2
Recruiting
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Enrollment
23 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT05868265 Phase 2
Recruiting
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
Enrollment
24 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT06823427 Phase 2
Recruiting
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Enrollment
60 pts
Location
China
Sponsor
Mabwell (Shanghai) Bioscience ...
NCT07164950
Recruiting
Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients
Enrollment
58 pts
Location
China
Sponsor
Sheng Zhang
NCT06262516
Recruiting
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
Enrollment
94 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent...